Prevalence of acute intermittent porphyria in a Mexican psychiatric population

Archives of Medical Research

Volumn 31, Issue 4, 2000, Pages 404-408

  Jara Prado, Aurelio ^a   Yescas, Petra ^a   Sánchez, Francisco Javier ^b   Ríos, Camilo ^a   Garnica, Rodrigo ^a   Alonso, Elisa ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

Author keywords

Acute intermittent porphyria; Asymptomatic carriers; Diagnosis; Porphobilinogen deaminase; Porphyria; Psychiatric populations

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE;

ACUTE INTERMITTENT PORPHYRIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HEREDITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MEXICO; URINALYSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALCOHOLISM; BORDERLINE PERSONALITY DISORDER; DEPRESSION; FEMALE; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; MALE; MEXICO; MIDDLE AGED; PEDIGREE; PERSONALITY DISORDERS; PORPHYRIA, ACUTE INTERMITTENT; PREVALENCE; SCHIZOPHRENIA, PARANOID; SUICIDE, ATTEMPTED;

EID: 0033786305     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(00)00092-8     Document Type: Article

References (31)

1. Intermittent acute porphyria-demonstration of a genetic defect in porphobilinogen metabolism
2. The porphyrias
3. Expression of the gene defect of acute intermittent porphyria in cultures human skin fibroblasts and amniotic cells; prenatal diagnosis of the porphyric trait
4. Molecular cloning and complete primary sequence of human erythrocyte PBG deaminase
5. Assignment of human porphobilinogen deaminase to 11q24.1-q24.2 by in situ hybridization and gene dosage studies
6. The UPS locus encoding uroporphyrinogen I synthase is located on human chromosome 11
7. 4 on chromosome 11
8. Assignment of human uroporphyrinogen I synthase locus to region 11 qter by gene dosage effect
9. Porphobilinogen gene structure and molecular defects
10. Prevention of acute porphyric attacks by intravenous haematin
11. Acute intermittent porphyria; clinical and selected research aspects
12. Grand mal seizures and acute intermittent porphyria
13. Postraumatic epilepsy and acute intermittent porphyria; effects of phenytoin, carbamazepine, and clonazepam
14. Seizure management in acute hepatic porphyria; risk of valproate and clonazepam
15. Safety of anticonvulsants in hepatic porphyrias
16. Carbamazepine-induced non-hereditary acute porphyria
17. Alterations in haem biosynthesis during the human menstrual cycle; studies in normal subjects and patients with latent and active acute intermittent porphyria
18. Porfirinas y pigmentos biliares
19. The neurological manifestations of porphyria; a review
20. Acute intermittent porphyria and mental illness-a family study
21. The porphyrias; recent advances
22. Urinary porphobilinogen
23. High prevalence of intermittent acute porphyria in a psychiatric patient population
24. Red blood porphobilinogen deaminase in the evaluation of acute intermittent porphyria
25. Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria
26. A simple test for urinary porphobilinogen
27. Urinary delta-aminolevulinic in lead poison. I. A modified method for the rapid determination of urinary delta-aminolevulinic acid using disposable ion-exchange chromatography columns
28. Detection of four novel mutations in the porphobilinogen deaminase gene in French Caucasian patients with acute intermittent porphyria
29. Acute intermittent porphyria rapid molecular diagnosis